#24-401 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Tele2 announces changes to the Group Leadership Team
Reading Time: 2 minutes Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Yogesh Malik, Executive Vice President and CTIO, will step down from his position effective from today. Yogesh joined Tele2 and the Group Leadership Team in April
Fondia Plc: Share repurchase 21.11.2024
Reading Time: < 1 minute Fondia Plc Company release 21.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 21.11.2024 Fondia Plc First North Finland Date 21.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 323 Average price/share, EUR 5,90
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 21.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024 Date 21.11.2024 Exchange transaction Buy Share class ALEX Amount 210 Average price/share 8.6500 EUR Highest
#24-119 ECOMB AB approved for listing at NGM
Reading Time: < 1 minute Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in ECOMB AB at NGM. The first day of trading has been set to November 25, 2024. The shares in ECOMB AB have
CasinoRank Explores iGaming Regulation Changes and Their Impact
Reading Time: 2 minutes November 21, 2024 — CasinoRank, a trusted authority in online casino industry, provides insights on regulatory changes shaping the global iGaming market. These changes, spanning multiple jurisdictions, are redefining the landscape for operators, players, and stakeholders worldwide. While many regions
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion
Reading Time: 2 minutes Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the
Alisa Bank Plc – Managers’ Transactions – Roine
Reading Time: < 1 minute ALISA BANK PLC MANAGER TRANSACTIONS 21.11.2024 AT 16.20 EET Person subject to the notification requirementName: Roine, JunnoPosition: Other senior managerIssuer: Alisa Bank PlcLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 743700VK1NB8HRGTQH74_20241121111539_18 Transaction date: 2024-11-21Venue not applicableInstrument type: SHAREISIN: FI4000170915Nature of the
New AI Studio Launched in Hyderabad
Reading Time: 3 minutes Ascendion’s Hyderabad AI Studio is designed to bring “Engineering to the Power of AI” tools to life. Driving enterprise transformation with real-time innovation and proven ROI across industries. Hyderabad’s vibrant tech ecosystem powers Ascendion’s vision
Biosergen Releases Interview with Principal Investigator Dr. Pawan Singh on Drug-Resistant Fungal Infections and BSG005
Reading Time: 2 minutes November 21, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, is pleased to announce the release of a fireside-chat-style video interview during the World Antimicrobial Resistance Awareness Week (WAAW). The video features the company’s CEO,